Omada Health, Inc. OMDA

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $260.21M · Filed Mar 6, 2026

Omada Health, Inc. (OMDA) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $260.2 million and a net loss of $12.8 million. Free cash flow was $16.9 million.

Revenue (TTM)
$309.76M
Net income (TTM)
$4.30M
Operating cash flow (TTM)
$23.68M
Free cash flow (TTM)
$22.73M
EPS (TTM)
$0.07
Dividend per share
None
Shares outstanding
58.93M
Net cash
$222.04M
FY 2025
Operating margin
-0.1%
FY 2026

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
OMDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1611115

Other Services-Health Services companies

All 17 Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2025
Dec 31, 2025
Revenue
$260.2M
Operating income
-$12.0M
Net income
-$12.8M
Diluted EPS
-$0.35
Operating cash flow
$18.3M
Free cash flow
$16.9M
Total assets
$305.4M
Total liabilities
$75.7M
Stockholders' equity
$229.7M
Cash and investments
$222.0M
Total debt
$0

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations, Officer or director change
 Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
 Jun 16, 2026 Jun 16, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
 May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025

All 235 Omada Health, Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.